Trademark Overview
On Wednesday, February 5, 2025, a trademark application was filed for AUMENOTO with the United States Patent and Trademark Office. The USPTO has given the AUMENOTO trademark a serial number of 99029214. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 5, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The AUMENOTO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy